Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hak Choy, MD
Vanderbilt-Ingram Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Centre Universitaire de Sante de L'Estrie - Site Fleurimont
Fleurimont, Quebec, Canada
- Jewish General Hospital - Montreal
Montreal, Quebec, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- Notre Dame Hospital
Montreal, Quebec, Canada
- Arizona Cancer Center
Tucson, Arizona, United States
- Cedars-Sinai Comprehensive Cancer Center
Los Angeles, California, United States
- James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Cancer Center of Albany Medical Center
Albany, New York, United States
- Cleveland Clinic Cancer Center
Cleveland, Ohio, United States
- Boston Cancer Group
Memphis, Tennessee, United States
- Dan Rudy Cancer Center
Nashville, Tennessee, United States
- Vanderbilt Cancer Center
Nashville, Tennessee, United States
- Massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 1998
- Primary completion
- 31 Jan 2003
- Completion
- 31 Jan 2003
- Last update posted
- 26 Aug 2021
- Registered enrollment
- —
- Registry id
- NCT00004202
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.